BRUSSELS SOUTH CHARLEROIBIOPARK

THE SCIENCE-DRIVEN BIOPARK AT THE HEART OF EUROPE

500 B€

YEARLY BIOTECH DEAL FLOW

Biopark

2000

HIGHLY SKILLED PEOPLE

Biopark

60

LIFE SCIENCE COMPANIES

Biopark

15

CLINICAL TRIALS SITES

Biopark

6

TECHNOLOGY PLATFORMS

Biopark

3

CROSS-FACULTY RESEARCH INSTITUTES

Biopark

MORE THAN 2,000 HIGHLY SKILLED PEOPLE FROM MORE THAN 30 COUNTRIES

OUR MISSION IS TO SUPPORT COMPANY GROWTH FROM INNOVATIVE START-UPS THROUGH TO GLOBAL PLAYERS

BIOPARK SKY VIEW

Testimonials

TESTIMONIALS

GREAT PLACE TO WORK

GREAT PLACE TO INVEST

GREAT PLACE TO GROW

MARGREET BROUWERSENIOR RESEARCH ASSISTANT AT Iteos Therapeutics

Testimonials

"As a former Research Assistant at ULB and now part of iTeos’ team, a biotech company headquartered here, I am delighted to see that the BioPark has attracted so many companies and people active in the life sciences sector and that it has evolved into a dynamic working environment with excellent amenities and social activities. The park’s unique cluster reinforces collaborations, stimulates knowledge sharing and creativity."

— Margreet Brouwer, Senior Research Assistant, Iteos Therapeutics

CHRIS BUYSEMANAGING PARTNER AT Fund+

Testimonials

"The BioPark’s cluster of innovative life sciences companies and their talented, multilingual and diverse work force together with the park’s state-of-the-art facilities make it an attractive place to invest. It provides an unique ecosystem of scientific, clinical and business expertise to progress early stage research and drug development through to stages offering excellent returns on investment with remarkable impact on society.”

— Chris Buyse, Managing Partner, Fund+

DENIS BEDORET PRESIDENT AT MaSTherCell Global

Testimonials

"The BioPark’s unique focus and expertise provide the perfect environment to grow your business into a fully-fledged, global company. The hands-on support we have received from the team, along with access to the BioPark’s outstanding services, have been a great help in establishing MTC as a distinguished, international cell therapy manufacturing company.”

— Denis Bedoret, President, MaSTherCell Global

WANT TO RECEIVE OUR MONTHLY NEWSLETTER?

NEWS

August 29th 2019

Des macrophages, des souris et des hommes…Le Pr Stanislas Goriely vient d’obtenir un Win2Wal pour un ambitieux programme de recherche en immuno-oncologie. Au cœur de ce projet, des souris « humanisées » qui vont aider les chercheurs à mieux c...

News

August 29th 2019

Passer de la recherche académique à la spin-offButterFly DrugDevBooster est un nouveau programme de maturation proposé aux chercheurs par BioPark Incubator. Son objectif : favoriser et accélérer la transition entre la recherche académique et la cr...

News

EVENTS

August 15th 2019

Coolerr Bags InformationPromethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, announced that clinical data from the ongoing phase 2a study of its lead product candidate HepaStem ® in patie...

15.08.2019 / 12:00 > 4:00 PM 58 Greta Street

Events

August 14th 2019

PROMETHERA BIOSCIENCES ANNOUNCES LATE-BREAKING DATA PRESENTATIONPromethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, announced that clinical data from the ongoing phase 2a study of its lead product candidate HepaStem ® in patie...

14.08.2019 / 7:00 > 12:00 PM ULiège - UMONS

Events